A Study of MEDI-575 in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069
- Status
- COMPLETED
- Phase
- PHASE1
Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin
- Status
- COMPLETED
- Phase
- PHASE1
A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects
- Status
- TERMINATED
- Phase
- PHASE1
To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue
- Status
- COMPLETED
- Phase
- PHASE1
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
- Status
- COMPLETED
- Phase
- PHASE3
A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
- Status
- WITHDRAWN
- Phase
- PHASE1
Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
- Status
- COMPLETED
- Phase
- N/A
Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment
- Status
- COMPLETED
- Phase
- N/A
Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
- Status
- COMPLETED
- Phase
- N/A
Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments
- Status
- COMPLETED
- Phase
- N/A
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
- Status
- COMPLETED
- Phase
- N/A
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1